Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study
Daria N Podlekareva, Joanne Reekie, Amanda Mocroft, Marcelo Losso, Aza G Rakhmanova, Elzbieta Bakowska, Igor A Karpov, Jeffrey V Lazarus, Jose Gatell, Jens D Lundgren, Ole Kirk, EuroSIDA study in EuroCoord, Daria N Podlekareva, Joanne Reekie, Amanda Mocroft, Marcelo Losso, Aza G Rakhmanova, Elzbieta Bakowska, Igor A Karpov, Jeffrey V Lazarus, Jose Gatell, Jens D Lundgren, Ole Kirk, EuroSIDA study in EuroCoord
Abstract
Background: State-of-the-art care involving the utilisation of multiple health care interventions is the basis for an optimal long-term clinical prognosis for HIV-patients. We evaluated health care for HIV patients based on four key indicators.
Methods: Four indicators of health care were assessed: Compliance with current guidelines on initiation of: 1) combination antiretroviral therapy (cART); 2) chemoprophylaxis; 3) frequency of laboratory monitoring; and 4) virological response to cART (proportion of patients with HIV-RNA < 500copies/ml for >90% of time on cART).
Results: 7097 EuroSIDA patients were included from Northern (n = 923), Southern (n = 1059), West Central (n = 1290) East Central (n = 1366), Eastern (n = 1964) Europe, and Argentina (n = 495). Patients in Eastern Europe with a CD4 < 200cells/mm(3) were less likely to initiate cART and Pneumocystis jiroveci-chemoprophylaxis compared to patients from all other regions, and less frequently had a laboratory assessment of their disease status. The proportion of patients with virological response was highest in Northern, 89% vs. 84%, 78%, 78%, 61%, 55% in West Central, Southern, East Central Europe, Argentina and Eastern Europe, respectively (p < 0.0001). Compared to Northern, patients from other regions had significantly lower odds of virological response; the difference was most pronounced for Eastern Europe and Argentina (adjusted OR 0.16 [95%CI 0.11-0.23, p < 0.0001]; 0.20[0.14-0.28, p < 0.0001] respectively).
Conclusions: This assessment of HIV health care utilization revealed pronounced regional differences in adherence to guidelines and can help to identify gaps and direct target interventions. It may serve as a tool for the assessment and benchmarking of the clinical management of HIV patients in any setting worldwide.
Figures
References
- EACS Guidelines. Clinical Management and Treatment of HIV-infected Adults in Europe. 2011. version 5–4. 26-8-2011. Available at: Accessed 24/08/2011.
- Gazzard BG, British HIV. Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med. 2008;9(8):563–608. doi: 10.1111/j.1468-1293.2008.00636.x.
- Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, USA; 2011. pp. 1–166. Available at Accessed 24/08/2011.
- HIV/AIDS Treatment and Care. Clinical protocols for the WHO European region. WHO Regional Office for Europe; 2009. Available at Accessed 24/08/2011.
- Global report: UNAIDS report on the global AIDS epidemic. UNAIDS; 2010. 10.11E | JC1958E. 25-8-2011. Available at Accessed 24/08/2011.
- Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F. et al.Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342(13):921–929.
- Horberg MA, Aberg JA, Cheever LW, Renner P, Kaleba EO, Asch SM. Development of National and Multiagency HIV Care Quality Measures. Clin Infect Dis. 2010;51(6):732–738. doi: 10.1086/655893. September 15.
- Samaranayake A, Chen MY, McNeil J, Read TRH, Hocking JS, Bradshaw CS. et al.Definitions of antiretroviral treatment failure for measuring quality outcomes. HIV Med. 2010;11(7):427–431.
- A guide on indicators for monitoring and reporting on the health sector response to HIV/AIDS. Handbook of indicators for key HIV interventions in the health sector. WHO; 2011. Available at Accessed 03/10/2011.
- Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio MA. et al.Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22–29. doi: 10.1016/S0140-6736(03)13802-0. July 5.
- Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD. et al.The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe–a review of published results. Cent Eur J Public Health. 2008;16(3):99–105. September.
- Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;18(41(RR-17)):1–19.
- Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR-4):1–207.
- Reekie J, Mocroft A, Ledergerber B, Beniowski M, Clotet B, van LJ. et al.History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change. HIV Med. 2010;11(7):469–478. August.
- Reekie J, Kowalska JD, Karpov I, Rockstroh J, Karlsson A, Rakhmanova A. et al.Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study. PLoS One. 2012;7(7):e41673. doi: 10.1371/journal.pone.0041673. July 23.
- Kiefe CI, Weissman NW, Allison JJ, Farmer R, Weaver M, Williams OD. Identifying achievable benchmarks of care: concepts and methodology. Int J Qual Health Care. 1998;10(5):443–447. doi: 10.1093/intqhc/10.5.443. October.
- Crabtree-Ramirez B, Caro-Vega Y, Shepherd BE, Wehbe F, Cesar C, Cortes C. et al.Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PLoS One. 2011;6(5):e20272. doi: 10.1371/journal.pone.0020272.
- Hamers FF, Downs AM. HIV in central and eastern Europe. Lancet. 2003;361:1035–1044. doi: 10.1016/S0140-6736(03)12831-0.
- Donoghoe MC, Bollerup AR, Lazarus JV, Nielsen S, Matic S. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002–2004. Int J Drug Policy. 2007;18(4):271–280. doi: 10.1016/j.drugpo.2007.02.010. August.
- Cohen D. HIV/AIDS is spreading fastest in eastern Europe and Asia. BMJ. 2004;329(7457):67. July 10.
Source: PubMed